Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex

Heemers, Hannelore V., Tindall, Donald J.·2007·Endocrine Reviews

Cited by (753)

Items 201–300 of 753

  1. Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
    Daisuke Obinata, Ken‐ichi Takayama, Satoru Takahashi, Satoshi Inoue · 2017 · Cancers
  2. Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders
    Nagendra K. Chaturvedi, Sanjay Kumar, Seema Negi, Rakesh K. Tyagi · 2010 · Molecular and Cellular Biochemistry
  3. Androgen receptor co-activators in the regulation of cellular events in prostate cancer
    Z. Culig, F. Santer · 2012 · World journal of urology
  4. Effect of non-enzymatic glycosylation in the epigenetics of cancer
    Shahnawaz Rehman, Mohammad Aatif, Zeeshan Rafi, Mohd Yasir Khan, Uzma Shahab, Saheem Ahmad, Mohd Farhan · 2020 · Seminars in Cancer Biology
  5. Reactive Oxygen Species Suppress Cardiac NaV1.5 Expression through Foxo1
    Weike Mao, Tao You, Bo Ye, Xiang Li, H. Henry Dong, Joseph A. Hill, Faqian Li, Haodong Xu · 2012 · PLoS ONE
  6. Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
    John M. McCoy, Carlos Gustavo Wambier, Sabina Herrera, Sérgio Vañó-Galván, F. Gioia, Belén Comeche, Raquel Ron, Sergio Serrano Villar, Rafal M. Iwasiow, Michael A Tayeb et al. · 2020 · Journal of the European Academy of Dermatology and Venereology
  7. ERK and AKT Signaling Drive MED1 Overexpression in Prostate Cancer in Association with Elevated Proliferation and Tumorigenicity
    Feng Jin, Shazia Irshad, Wei Yu, Madesh Belakavadi, Marina A. Chekmareva, Michael Ittmann, Cory T. Abate-Shen, Joseph D. Fondell · 2013 · Molecular Cancer Research
  8. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures
    Indranil Chattopadhyay, Jianmin Wang, Maochun Qin, Lingqiu Gao, Renae Holtz, Robert L. Vessella, Robert W. Leach, Irwin H. Gelman · 2016 · Oncotarget
  9. Androgen Physiology: Receptor and Metabolic Disorders
    Iain J. McEwan, Albert O. Brinkmann · 2016
  10. Redefining hormone resistance in prostate cancer
    Christopher J. Hoimes, William Kevin Kelly · 2009 · Therapeutic Advances in Medical Oncology
  11. The Stress Response Mediator ATF3 Represses Androgen Signaling by Binding the Androgen Receptor
    Hongbo Wang, Ming Jiang, Hongmei Cui, Mengqian Chen, Ralph Buttyan, Simon W. Hayward, Tsonwin Hai, Zhengxin Wang, Chunhong Yan · 2012 · Molecular and Cellular Biology
  12. Aging Impairs VEGF-Mediated, Androgen-Dependent Regulation of Angiogenesis
    Laura Lecce, Yuen Ting Lam, Laura A. Lindsay, Sui Ching G. Yuen, Philippa J. L. Simpson, David J. Handelsman, Martin Ng · 2014 · Molecular Endocrinology
  13. Androgen receptor expression in human thyroid cancer tissues: A potential mechanism underlying the gender bias in the incidence of thyroid cancers
    Jone Arulrajadurai Stanley, Mariajoseph Michael Aruldhas, M. Chandrasekaran, Ramalingam Neelamohan, Esakky Suthagar, Kannan Annapoorna, S Sharmila, J Jayakumar, G. Jayaraman, N. Srinivasan et al. · 2012 · The Journal of Steroid Biochemistry and Molecular Biology
  14. Androgen receptor as a therapeutic target
    Wenqing Gao · 2010 · Advanced Drug Delivery Reviews
  15. Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain
    Carmen Adriana Banuelos, Aaron Lal, Amy H. Tien, Neel Shah, Yu Chi Yang, Nasrin R. Mawji, Labros G. Meimetis, Jacob Park, Kunzhong Jian, Raymond J. Andersen et al. · 2014 · PLoS ONE
  16. Androgen receptor co-regulation in prostate cancer
    Dhirodatta Senapati, Sangeeta Kumari, Hannelore V. Heemers · 2019 · Asian journal of urology
  17. Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Edwin E. Reyes, David James VanderWeele, Masis Isikbay, Ryan Duggan, Alexa Campanile, Walter Michael Stadler, Donald J Vander Griend, Russell Zelig Szmulewitz · 2014 · Journal of Translational Medicine
  18. Androgen receptor molecular biology and potential targets in prostate cancer
    Elizabeth M. Wilson · 2010 · Therapeutic Advances in Urology
  19. Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase
    Mohammad Asim, Bilal Bin Hafeez, Imtiaz Ahmad Siddiqui, Claudia Gerlach, Michaela Patz, Hasan Mukhtar, Aria Baniahmad · 2011 · Journal of Biological Chemistry
  20. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants
    Laura R. Bohrer, Ping Liu, Jian Zhong, Yunqian Pan, James F. Angstman, Lucas J. Brand, Scott M. Dehm, Haojie Huang · 2013 · The Prostate
  21. Association of Genetic Polymorphisms in the LncRNAs with Gastric Cancer Risk in a Chinese Population
    Bangshun He, Huiling Sun, Tao Xu, Yuqin Pan, Lin Kang, Tianyi Gao, Zhenyu Zhang, Shukui Wang · 2017 · Journal of Cancer
  22. Segment-specific regulation of epididymal gene expression
    Petra Sipilä, Ida Björkgren · 2016 · Reproduction
  23. A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells
    Keren Imberg-Kazdan, Susan Ha, Alex Greenfield, Christopher S. Poultney, Richard Bonneau, Susan K. Logan, Michael J. Garabedian · 2013 · Genome Research
  24. Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression
    Lucas J. Brand, Scott M. Dehm · 2013 · Current Drug Targets
  25. MST1 Is a Multifunctional Caspase-Independent Inhibitor of Androgenic Signaling
    Bekir Cinar, Filiz Kisaayak Collak, Delia Lopez, Seçkin Akgül, Nishit K. Mukhopadhyay, Murat Kilicarslan, Daniel G. Gioeli, Michael R. Freeman · 2011 · Cancer Research
  26. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets
    Sari Toropainen, Einari A. Niskanen, Marjo Malinen, Päivi Sutinen, Minna Unelma Kaikkonen, Jorma J. Palvimo · 2016 · Scientific Reports
  27. Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
    Miriam Kokal, Kimia Mirzakhani, Thanakorn Pungsrinont, Aria Baniahmad · 2020 · Cancers
  28. Muscle specific miRNAs are induced by testosterone and independently upregulated by age
    Søren J. Nielsen, Thine Hvid, Meghan Kelly, Birgitte Lindegaard, Christine Dethlefsen, Kamilla Munch Winding, Neha Mathur, Camilla Schéele, Bente Klarlund Pedersen, Matthew James Laye · 2014 · Frontiers in Physiology
  29. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of gastric cancer
    Lijuan Li, Jia Fu, Peng Bai, Yundan Liang, Ruifen Sun, Fang Yuan, Lin Zhang, Linbo Gao · 2015 · Tumor Biology
  30. BAP18 coactivates androgen receptor action and promotes prostate cancer progression
    Shiying Sun, Xinping Zhong, Chunyu Wang, Hongmiao Sun, Shengli Wang, Tingting Zhou, Renlong Zou, Lin Lin, Ning Sun, Ge Sun et al. · 2016 · Nucleic Acids Research
  31. Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development
    Wojciech Kowalczyk, Grzegorz Waliszczak, Robert Jach, Joanna Dulińska-Litewka · 2021 · Cancers
  32. Molecular pathology and prostate cancer therapeutics: from biology to bedside
    Daniel Nava Rodrigues, Lisa M. Butler, David Lorente Estelles, Johann Sebastian De Bono · 2013 · The Journal of Pathology
  33. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells
    Mohsen Esmaeili, Susanne Jennek, Susann Ludwig, Alexandra Klitzsch, Florian Kraft, Christian Melle, Aria Baniahmad · 2016 · Journal of Molecular Cell Biology
  34. Prostate cancer: the need for biomarkers and new therapeutic targets
    Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha · 2014 · Journal of Zhejiang University SCIENCE B
  35. Mechanism of the Tissue-Specific Action of the Selective Androgen Receptor Modulator S-101479
    Kazuyuki Furuya, Noriko Yamamoto, Yuki Ohyabu, Teruyuki Morikyu, Hirohide Ishige, Michael Albers, Yasuhisa Endo · 2013 · Biological and Pharmaceutical Bulletin
  36. An Androgen Receptor-MicroRNA-29a Regulatory Circuitry in Mouse Epididymis
    Wubin Ma, Shuanggang Hu, Guangxin Yao, Shengsong Xie, Minjie Ni, Qiang Liu, Xinxing Gao, Jun Zhang, Xingxu Huang, Yonglian Zhang · 2013 · Journal of Biological Chemistry
  37. New drugs in prostate cancer
    Sangjun Yoo, Se Young Choi, Dalsan You, Choung‐Soo Kim · 2016 · Prostate International
  38. Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
    Haozhe Zhang, Zhou Yi, Zengzhen Xing, Rajiv Kumar Sah, Junqi Hu, Hailiang Hu · 2022 · International Journal of Molecular Sciences
  39. Androgen-induced epigenetic modulations in the ovary
    Irving Salinas, Niharika Sinha, Aritro Sen · 2021 · Journal of Endocrinology
  40. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer
    Lidia Chellini, Marco Pieraccioli, Claudio Sette, Maria Paola Paronetto · 2022 · Journal of Experimental & Clinical Cancer Research
  41. Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries
    Daisuke Obinata, Ken‐ichi Takayama, Satoshi Inoue, Satoru Takahashi · 2024 · International Journal of Urology
  42. Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
    Kristine M. Wadosky, Shahriar Koochekpour · 2016 · International Journal of Biological Sciences
  43. Associations between Blood and Urine Arsenic Concentrations and Global Levels of Post-Translational Histone Modifications in Bangladeshi Men and Women
    Caitlin G. Howe, Xinhua Liu, Megan N. Hall, Vesna N. Slavkovich, Vesna Ilievski, Faruque Parvez, Abu B. Siddique, Hasan Shahriar, Mohammad Nasir Uddin, Tariqul Islam et al. · 2016 · Environmental Health Perspectives
  44. Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity: lessons from a meta-analysis and rodent studies
    Naoki Harada · 2018 · Bioscience Biotechnology and Biochemistry
  45. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells
    Hongjuan Zhao, Vincent Flamand, Donna M. Peehl · 2009 · BMC Medical Genomics
  46. Discovering modulators of gene expression
    Özgün Babur, Emek Demir, Mithat Gönen, Chris Sander, Uğur Doğrusöz · 2010 · Nucleic Acids Research
  47. Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
    Derek N. Lavery, Charlotte Lynne Bevan · 2010 · BioMed Research International
  48. Resveratrol Inhibits Hypoxia-Inducible Factor-1^|^alpha;-Mediated Androgen Receptor Signaling and Represses Tumor Progression in Castration-Resistant Prostate Cancer
    Takakazu Mitani, Naoki Harada, Shinji Tanimori, Yoshihisa Nakano, Hiroshi Inui, Ryoichi Yamaji · 2014 · Journal of Nutritional Science and Vitaminology
  49. Novel and next-generation androgen receptor–directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
    Richard Martin Bambury, Dana E. Rathkopf · 2015 · Urologic Oncology Seminars and Original Investigations
  50. Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
    Shahriar Koochekpour, Erick Buckles, Mojgan Shourideh, SiYi Hu, Dhyan Chandra, Jovanny Zabaleta, Kristopher M. Attwood · 2014 · International Journal of Biological Sciences
  51. TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth
    Joseph H. Jeong, Ayesha Bhatia, Zsolt Toth, Soohwan Oh, Kyung‐Soo Inn, Chun‐Peng Liao, Pradip Roy‐Burman, Jonathan Melamed, Gerhard A. Coetzee, Jae Ung Jung · 2011 · PLoS ONE
  52. The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth
    Daniela Brünnert, Clara Langer, Luise Zimmermann, Ralf Christian Bargou, Martin Burchardt, Manik Chatterjee, Matthias Bernhard Stope · 2019 · Journal of Cellular Biochemistry
  53. Prostaglandin 15d-PGJ2 Inhibits Androgen Receptor Signaling in Prostate Cancer Cells
    Sanna Kaikkonen, Ville Paakinaho, Päivi Sutinen, Anna–Liisa Levonen, Jorma J. Palvimo · 2012 · Molecular Endocrinology
  54. Maintenance of Androgen Receptor Inactivation by S-Nitrosylation
    Qin Yu, Anindya Dey, Hamsa Thayele Purayil, Yehia Daaka · 2013 · Cancer Research
  55. Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery
    Sugunadevi Sakkiah, Hui Wen Ng, Weida Tong, Huixiao Hong · 2016 · Expert Opinion on Therapeutic Targets
  56. Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy
    Javier Duran, Daniel Lagos, Mario Pávez, Mayarling Francisca Troncoso, Sebastián Ramos, Genaro C. Barrientos, Cristián Ibarra, Sergio Lavandero, Manuel Estrada · 2017 · Frontiers in Pharmacology
  57. Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II)
    Nadine Hornig, Pascal Rodens, Helmuth G. Dörr, Nina C. Hubner, Alexandra E. Kulle, Hans‐Udo Schweikert, Maik Welzel, Susanne Bens, Olaf Hiort, Ralf Werner et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
  58. Mechanisms of prostate cancer progression to androgen independence
    Michael John McPhaul · 2008 · Best Practice & Research Clinical Endocrinology & Metabolism
  59. Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration
    Alissa R. Verone, Kelly Duncan, Alejandro Godoy, N. Yadav, Andrei V. Bakin, Shahriar Koochekpour, Jian‐Ping Jin, Hannelore V. Heemers · 2013 · Carcinogenesis
  60. WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation
    Kai Song, He Sun, Bin Tu, Yang Zhou, Li-Chan Lin, Zhiyan Liu, Rui Li, Jingjing Yang, Ye Zhang, Jian‐Yuan Zhao et al. · 2023 · iScience
  61. Exploring the effects of Chinese herbal ingredients on the signaling pathway of alopecia and the screening of effective Chinese herbal compounds
    Jinjin Dou, Zhiming Zhang, Xianrong Xu, Xiwu Zhang · 2022 · Journal of Ethnopharmacology
  62. The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS.
    Nicoleta Băculescu · 2013 · Europe PMC (PubMed Central)
  63. Unraveling the Complexities of Androgen Receptor Signaling in Prostate Cancer Cells
    Hannelore V. Heemers, Donald J. Tindall · 2009 · Cancer Cell
  64. Molecular Phenotyping of Immune Cells from Young NOD Mice Reveals Abnormal Metabolic Pathways in the Early Induction Phase of Autoimmune Diabetes
    Wu, Jian, Kakoola, Dorothy N., Lenchik, Nataliya I., Desiderio, Dominic M., Marshall, Dana R., Gerling, Ivan C. · 2012 · PLoS ONE
  65. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
    Dustin H. Marks, Sonya Prasad, Brianna De Souza, Laura J. Burns, Maryanne Makredes Senna · 2019 · American Journal of Clinical Dermatology
  66. Molecular insights into Sertoli cell function: how do metabolic disorders in childhood and adolescence affect spermatogonial fate?
    Rossella Cannarella, Roberto Curto, Rosita Angela Condorelli, Scott D. Lundy, Sandro La Vignera, Aldo Eugenio Calogero · 2024 · Nature Communications
  67. Novel secondary hormonal therapy in advanced prostate cancer: an update
    Eliezer M. Van Allen, Charles J. Ryan · 2009 · Current Opinion in Urology
  68. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer
    Zhonglin Cai, Weijie Chen, Jianzhong Zhang, Hongjun Li · 2018 · International Urology and Nephrology
  69. Influence of androgens on the innate immune system
    Seline Y. Vancolen, Guillaume Sébire, Bernard Robaire · 2023 · Andrology
  70. PAGE4 Positivity Is Associated with Attenuated AR Signaling and Predicts Patient Survival in Hormone-Naive Prostate Cancer
    Natalie Sampson, Christian Felipe Ruiz, Christoph Zenzmaier, Lukas Bubendorf, Peter Berger · 2012 · American Journal Of Pathology
  71. ELF3 is a repressor of androgen receptor action in prostate cancer cells
    Aymen A. Shatnawi, John D. Norris, Cédric Chaveroux, Jeff S. Jasper, Andrea B. Sherk, Donald Patrick McDonnell, Vincent Giguère · 2013 · Oncogene
  72. Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer
    Bin Wang, U‐Ging Lo, Kaijie Wu, Payal Kapur, Xiangyang Liu, Jun Xing Huang, Wei Chen, Elizabeth Hernández, John Santoyo, Shihong Ma et al. · 2017 · International Journal of Cancer
  73. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma
    Yun‐Sok Ha, Geun Taek Lee, Parth K. Modi, Young Suk Kwon, Hanjong Ahn, Wun‐Jae Kim, Isaac Yi Kim · 2015 · The Journal of Urology
  74. Association between genetic polymorphisms of long non‑coding RNA PRNCR1 and prostate cancer risk in a sample of the Iranian population
    Hedieh Sattarifard, Mohammad Mostakhdem Hashemi, Shekoofeh Hassanzarei, Behzad Narouie, Gholamreza Bahari · 2017 · Molecular and Clinical Oncology
  75. Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide
    Zhe Hong, Zhendong Xiang, Pan Zhang, Qiang Wu, Chengdang Xu, Xinan Wang, Guowei Shi, Zongyuan Hong, Denglong Wu · 2021 · Clinical and Translational Medicine
  76. Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
    Tomislav P. Pejcic, Zoran Todorović, Siniša Đurašević, LAZAR S. POPOVIC · 2023 · International Journal of Molecular Sciences
  77. Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activity
    Alexandra Kollara, Theodore J. Brown · 2009 · The Journal of Steroid Biochemistry and Molecular Biology
  78. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Takakazu Mitani, Naoki Harada, Shinji Tanimori, Yoshihisa Nakano, Hiroshi Inui, Ryoichi Yamaji · 2014 · PubMed
  79. Androgen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent Transactivation
    William H. Lagarde, Amanda J. Blackwelder, John T. Minges, Andrew T. Hnat, Frank S. French, Elizabeth M. Wilson · 2012 · Journal of Biological Chemistry
  80. ARF Represses Androgen Receptor Transactivation in Prostate Cancer
    Wenfu Lu, Yingqiu Xie, Yufang Ma, Robert J. Matusik, Zhenbang Chen · 2013 · Molecular Endocrinology
  81. MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3β signaling impedes castration-resistant prostate cancer growth
    Jinbo Sun, Xiangnan Hu, Yongheng Gao, Qisheng Tang, Zhining Zhao, Wenjin Xi, Fan Yang, Wei Zhang, Yue Song, Bin Song et al. · 2019 · Aging
  82. Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer
    Zhuoyuan Lin, Shivani Agarwal, Song Tan, Hongshun Shi, Xiaodong Lü, Zhipeng Tao, Xuesen Dong, Xu Wu, Jonathan C. Zhao, Jindan Yu · 2023 · Oncogene
  83. Modulation of Nuclear Receptor Function by Chromatin Modifying Factor TIP60
    Bharti Jaiswal, Ashish K. Gupta · 2018 · Endocrinology
  84. Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism
    Li Jin, Qian Yang, Chengliang Zhou, Lanxin Liu, Huihui Helen Wang, Min Hou, Yimei Wu, Feng-Tao Shi, Jian‐Zhong Sheng, Hefeng Huang · 2018 · Reproductive BioMedicine Online
  85. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen
    Hannah Weber, Rachel Ruoff, Michael J. Garabedian · 2021 · PLoS Genetics
  86. Quantitative measurement of the androgen receptor in prepuces of boys with and without hypospadias
    Renate Pichler, Gabriel Djedovic, Helmut Klocker, Isabel Maria Heidegger, Alexander M. Strasak, Wolfgang C. Loidl, Jasmin Bektić, Viktor Skradski, Wolfgang Horninger, Josef Oswald · 2013 · British Journal of Urology
  87. Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action
    Adam D. DePriest, Michael V. Fiandalo, Simon E. Schlanger, Frederike Heemers, James Lloyd Mohler, Song Liu, Hannelore V. Heemers · 2016 · Database
  88. Differential Requirement for Src Family Tyrosine Kinases in the Initiation, Progression, and Metastasis of Prostate Cancer
    Irwin H. Gelman, Jennifer Peresie, Kevin Hasegawa Eng, Barbara A. Foster · 2014 · Molecular Cancer Research
  89. Androgen signaling expands β-cell mass in male rats and β-cell androgen receptor is degraded under high-glucose conditions
    Naoki Harada, Yasuhiro Yoda, Yusuke Yotsumoto, Tatsuya Masuda, Yūji Takahashi, Takahiro Katsuki, Kenji Kai, Nobuaki Shiraki, Hiroshi Inui, Ryoichi Yamaji · 2017 · American Journal of Physiology-Endocrinology and Metabolism
  90. Androgen Receptor Dependence
    Aashi P. Chaturvedi, Scott M. Dehm · 2019 · Advances in experimental medicine and biology
  91. Androgen Receptor (AR)-TLR4 Crosstalk Mediates Gender Disparities in Hepatocellular Carcinoma Incidence and Progression
    Qiuju Han, Dan Yang, Chunlai Yin, Jian Zhang · 2019 · Journal of Cancer
  92. TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2‐mediated degradation
    Mi Chen, Shreyas Lingadahalli, Nitin P. Narwade, Kate M. K. Lei, Shanshan Liu, Zuxianglan Zhao, Yimin Zheng, Qian Lü, Alexander Hin Ning Tang, Terence Chuen Wai Poon et al. · 2022 · EMBO Reports
  93. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2
    Woo‐Young Seo, Byong Chang Jeong, E. J. Yu, Hyung Jun Kim, S.-H. Kim, Ji Eun Lim, Ghee Young Kwon, H. M. Lee, J. H. Kim · 2013 · Nucleic Acids Research
  94. Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes
    Miltiadis Paliouras, Naif Zaman, Rose Lumbroso, L Kapogeorgakis, Lenore K. Beitel, Edwin Wang, Mark A. Trifiro · 2011 · Integrative Biology
  95. Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement
    Hamilton, Blair R., Lima, Giscard, Barrett, James, Seal, Leighton, Kolliari-Turner, Alexander, Wang, Guan, Karanikolou, Antonia, Bigard, Xavier, Löllgen, Herbert, Zupet, Petra et al. · 2021 · Sports Medicine
  96. Androgen receptor abnormalities in castration-recurrent prostate cancer.
    Nacusi, Lucas P, Tindall, Donald J · 2009 · Expert Review of Endocrinology & Metabolism
  97. Usefulness of Preoperative Serum Testosterone as a Predictor of Extraprostatic Extension and Biochemical Recurrence
    Hyoung Jong Kim, Byung Hoon Kim, Chol Hee Park, Chun Il Kim · 2012 · Korean journal of urology
  98. Revisiting the relationships of 2D:4D with androgen receptor (AR) gene and current testosterone levels: Replication study and meta‐analyses
    Kejin Zhang, Xing Yang, Mengfei zhang, Chunlan Wang, Pengpeng Fang, Mengying Xue, Jing Zhao, Xiaocai Gao, Ruliang L. Pan, Pingyuan Gong · 2019 · Journal of Neuroscience Research
  99. Advances in PARP Inhibitors for Prostate Cancer
    Steven Tisseverasinghe, Boris Bahoric, Maurice Anidjar, Stephan Probst, Tamim Mohammad Niazi · 2023 · Cancers
  100. Targeting sex steroid biosynthesis for breast and prostate cancer therapy
    Matti H. POUTANEN, Malin Hagberg Thulin, Pirkko L. Härkönen · 2023 · Nature reviews. Cancer